Skip to main content
2024 Guide to Patient Support Services

Daiichi-Sankyo

2024 PSS Guide

Daiichi-Sankyo Access Central Support Program

Daiichi-Sankyo’s Access Central offers comprehensive reimbursement and support services for patients who are prescribed Injectafer or Turalio (Table).

Access Central Support Programs

Injectafer Savings Program

The Injectafer Savings Program helps eligible patients with out-of-pocket Injectafer prescription costs. Uninsured and cash-paying patients are not eligible for this program.

Check eligibility criteria and enroll your patient by calling 866-437-4669 or Injectafer Savings Program.

Injectafer Patient Assistance Program

Patients who are uninsured or commercially underinsured and need help paying for their Injectafer treatment may be eligible for the Injectafer Patient Assistance Program.

Check eligibility criteria and enroll your patient by calling 866-437-4669 or Injectafer Patient Assistance Program.

Turalio QuickStart Program

Patients experiencing a 5-day delay in getting their prescription may be eligible for the Turalio QuickStart Program.

Check eligibility criteria and enroll your patient by calling 800-850-4306 or visiting Turalio QuickStart Program.

Turalio Copay Program

Qualifying patients may pay as little as $0 per prescription of Turalio, with a maximum benefit of $25,000 per calendar year.

Check eligibility criteria and enroll your patient by calling 800-850-4306 or visiting Turalio Copay Program.

Turalio Patient Assistance Program

The Turalio Patient Assistance Program may provide Turalio at no cost for financially eligible patients who are uninsured or underinsured. Eligibility criteria may be met if the patient has been denied coverage, is uninsured, or is functionally uninsured (denied prior authorization, formulary exclusion).

Medicare enrollees may be eligible for the Turalio Patient Assistance Program if they are unable to meet their out-of-pocket costs for Turalio and meet the required income criteria. Additional terms and conditions apply. Enroll your patient by calling 866-437-4669 or visiting Turalio Patient Assistance Program.

TABLE Daiichi-Sankyo Oncology/Supportive Care Drugs

Drugs
Indications
Patient support programs

Drug
Injectafer (ferric carboxymaltose injection)
Indications
Treatment of iron-deficiency anemia in adults and pediatric patients ≥1 year of age who are intolerant to or have had an unsatisfactory response to oral iron replacement therapy; treatment of adults with non–dialysis-dependent chronic kidney disease; treatment of iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity.
Patient support programs

Drug
Turalio (pexidartinib) capsules
Indications
Treatment of adult patients with symptomatic tenosynovial giant-cell tumor associated with severe morbidity or functional limitations and not amenable to improvement with surgery
Patient support programs